senate Bill S1236

2017-2018 Legislative Session

Regulates the sale of methamphetamine precursor drugs

download bill text pdf

Sponsored By

Archive: Last Bill Status - Passed Senate


  • Introduced
  • In Committee
  • On Floor Calendar
    • Passed Senate
    • Passed Assembly
  • Delivered to Governor
  • Signed/Vetoed by Governor

Your Voice

do you support this bill?

Please enter your contact information

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.

Actions

view actions (15)
Assembly Actions - Lowercase
Senate Actions - UPPERCASE
Jun 19, 2018 referred to consumer affairs and protection
delivered to assembly
passed senate
Feb 27, 2018 advanced to third reading
Feb 13, 2018 2nd report cal.
Feb 12, 2018 1st report cal.460
Jan 03, 2018 referred to consumer protection
returned to senate
died in assembly
Jun 19, 2017 referred to consumer affairs and protection
delivered to assembly
passed senate
ordered to third reading cal.1851
Jun 06, 2017 reported and committed to rules
Jan 06, 2017 referred to consumer protection

Votes

view votes

Feb 12, 2018 - Consumer Protection committee Vote

S1236
10
0
committee
10
Aye
0
Nay
0
Aye with Reservations
0
Absent
1
Excused
0
Abstained
show Consumer Protection committee vote details

Consumer Protection Committee Vote: Feb 12, 2018

excused (1)

Jun 19, 2017 - Rules committee Vote

S1236
23
0
committee
23
Aye
0
Nay
2
Aye with Reservations
0
Absent
0
Excused
0
Abstained
show Rules committee vote details

Jun 6, 2017 - Consumer Protection committee Vote

S1236
11
0
committee
11
Aye
0
Nay
0
Aye with Reservations
0
Absent
0
Excused
0
Abstained
show Consumer Protection committee vote details

Consumer Protection Committee Vote: Jun 6, 2017

Co-Sponsors

view additional co-sponsors

S1236 (ACTIVE) - Details

Law Section:
General Business Law
Laws Affected:
Add §391-oo, Gen Bus L
Versions Introduced in Other Legislative Sessions:
2013-2014: S4652
2015-2016: S627

S1236 (ACTIVE) - Summary

Regulates the sale of methamphetamine precursor drugs.

S1236 (ACTIVE) - Sponsor Memo

S1236 (ACTIVE) - Bill Text download pdf


                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                  1236

                       2017-2018 Regular Sessions

                            I N  S E N A T E

                             January 6, 2017
                               ___________

Introduced  by  Sens.  VALESKY,  AKSHAR, DeFRANCISCO, O'MARA, RITCHIE --
  read twice and ordered printed, and when printed to  be  committed  to
  the Committee on Consumer Protection

AN  ACT  to  amend  the general business law, in relation to the sale of
  over-the-counter methamphetamine precursor drugs

  THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section 1. The general business law is amended by adding a new section
391-oo to read as follows:
  § 391-OO. SALE OF METHAMPHETAMINE PRECURSOR DRUGS. 1. FOR THE PURPOSES
OF THIS SECTION:
  (A) "METHAMPHETAMINE PRECURSOR DRUG" SHALL MEAN ANY COMPOUND, MIXTURE,
OR  PREPARATION  CONTAINING  EPHEDRINE  OR  PSEUDOEPHEDRINE  AS ITS SOLE
ACTIVE INGREDIENT OR AS ONE OF ITS ACTIVE INGREDIENTS; AND
  (B) "REAL-TIME STOP SALE SYSTEM" MEANS A SYSTEM INTENDED TO BE USED BY
LAW ENFORCEMENT AGENCIES AND PHARMACIES OR OTHER BUSINESS ESTABLISHMENTS
THAT:
  (A) IS INSTALLED, OPERATED, AND MAINTAINED FREE  OF  ANY  ONE-TIME  OR
RECURRING CHARGE TO THE BUSINESS ESTABLISHMENT OR TO THE STATE;
  (B)  IS ABLE TO COMMUNICATE IN REAL TIME WITH SIMILAR SYSTEMS OPERATED
IN OTHER STATES AND SIMILAR SYSTEMS CONTAINING INFORMATION SUBMITTED  BY
MORE THAN ONE STATE;
  (C) COMPLIES WITH THE SECURITY POLICY OF THE CRIMINAL JUSTICE INFORMA-
TION SERVICES DIVISION OF THE FEDERAL BUREAU OF INVESTIGATION;
  (D)  COMPLIES  WITH  INFORMATION  EXCHANGE  STANDARDS  ADOPTED  BY THE
NATIONAL INFORMATION EXCHANGE MODEL;
  (E) USES A MECHANISM TO PREVENT THE COMPLETION OF A SALE OF A  PRODUCT
CONTAINING EPHEDRINE, PSEUDOEPHEDRINE, OR NON-PSEUDOEPHEDRINE THAT WOULD
VIOLATE  STATE  OR  FEDERAL  LAW  REGARDING  THE  PURCHASE  OF A PRODUCT
CONTAINING THOSE SUBSTANCES; AND
  (F) IS EQUIPPED WITH AN OVERRIDE OF THE MECHANISM THAT:

 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.

Comments

Open Legislation comments facilitate discussion of New York State legislation. All comments are subject to moderation. Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity or hate speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Comment moderation is generally performed Monday through Friday.

By contributing or voting you agree to the Terms of Participation and verify you are over 13.